Evidence map›Paper›PMID 18442200›Full record

ArticleWorld journal of gastroenterology2008

T cell responses to hepatitis B surface antigen are detectable in non-vaccinated individuals.

Martin R Weihrauch, Michael von Bergwelt-Baildon, Milos Kandic, Martin Weskott, Winfried Klamp, Joachim Rosler, Joachim L Schultze

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Observational
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Martin R WeihrauchMolecular Tumor Biology and Tumor Immunology, University of Cologne, Köln 50924, Germany. martin.weihrauch@uni-koeln.de
Michael von Bergwelt-Baildon
Milos Kandic
Martin Weskott
Winfried Klamp
Joachim Rosler
Joachim L Schultze
Alexander von Humboldt Foundation · DEStadtwerke Offenbach (Germany) · DEUniversity of Cologne · DEAga Khan University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate, whether humoral hepatitis-B-vaccine non-responders also fail to mount a T cell response and to compare these results to normal vaccinees.

methodsFourty-seven health care employees were enrolled in this study including all available non-responders (n = 13) with an anti-HBsAg titer < 10 kU/L and all available low-responders (n = 12) with an anti-HBsAg titer < 100 kU/L. Also, 12 consecutive anti-HBsAg negative pre-vaccination subjects were enrolled as well as 10 subjects (+7 from the vaccinated group) with titers > 1000 kU/L as controls. PBMC from all subjects were analyzed by IFN-gamma and IL-4 ELISPOT assays for the presence of hepatitis B surface antigen (HBsAg) reactive T cells.

resultsNon-responders and low-responders had no or only very limited T cell responses, respectively. Individuals responding to vaccination with the induction of a high anti-HBsAg titer showed a strong T cell response after the third vaccination. Surprisingly, these individuals showed response even before the first vaccination. T cell response to control antigens and mitogens was similar in all groups.

conclusionOur data suggest that there is no general immune deficiency in non-/low-responders. Thus, we hypothesize that the induction of anti-HBsAg responses by vaccination is significantly dependent on the pre-existing T cell repertoire against the specific antigen rather than the presence of a general T cell defect.

Indexed as

Treatment RefusalAdultCarrier StateFemaleGlobal HealthHepatitis BHepatitis B Surface AntigensHepatitis B VaccinesHumansLeukocytes, MononuclearLiver CirrhosisLymphocyte ActivationMaleMiddle AgedPrevalenceT-LymphocytesHepatitis B Surface AntigensHepatitis B Vaccines

Identifiers

PMID18442200
PMCPMC2708364
OpenAlexW1965764489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.